Skip to main content
TipRanks
Go Ultimate75% OFF

Nanjing Leads Biolabs Co., Ltd. Class H (9887) Ratios

4 Followers

Nanjing Leads Biolabs Co., Ltd. Class H Ratios

HK:9887's free cash flow for Q2 2026 was ¥0.00. For the 2026 fiscal year, HK:9887's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio3.371.500.260.44
Quick Ratio3.251.500.260.44
Cash Ratio2.430.940.180.21
Solvency Ratio-0.42-0.10-0.27-0.22
Operating Cash Flow Ratio-0.31-0.30-0.14-0.04
Short-Term Operating Cash Flow Coverage-0.59-0.47-3.16-0.04
Net Current Asset Value¥ 1.17B¥ 192.42M¥ -1.03B¥ -681.75M
Leverage Ratios
Debt-to-Assets Ratio0.160.400.151.93
Debt-to-Equity Ratio0.221.00-0.07-1.98
Debt-to-Capital Ratio0.180.50-0.082.02
Long-Term Debt-to-Capital Ratio0.000.000.000.00
Financial Leverage Ratio1.412.52-0.47-1.03
Debt Service Coverage Ratio-0.80-0.14-4.29-0.17
Interest Coverage Ratio-30.91-6.91-206.45-704.00
Debt to Market Cap0.030.030.010.11
Interest Debt Per Share1.651.810.476.29
Net Debt to EBITDA4.822.880.67-4.79
Profitability Margins
Gross Profit Margin100.00%0.00%64.07%0.00%
EBIT Margin-109.75%0.00%-2969.26%0.00%
EBITDA Margin-98.99%0.00%-2746.59%0.00%
Operating Profit Margin-109.75%0.00%-2969.26%0.00%
Pretax Profit Margin-110.51%0.00%-4086.28%0.00%
Net Profit Margin-119.27%0.00%-4086.28%0.00%
Continuous Operations Profit Margin-119.27%0.00%-4086.28%0.00%
Net Income Per EBT107.93%100.00%100.00%100.00%
EBT Per EBIT100.70%110.18%137.62%134.29%
Return on Assets (ROA)-13.20%-6.56%-89.08%-46.60%
Return on Equity (ROE)-18.58%-16.53%42.01%47.96%
Return on Capital Employed (ROCE)-16.92%-14.70%30.58%35.96%
Return on Invested Capital (ROIC)-14.00%-7.49%32.85%-36.33%
Return on Tangible Assets-13.22%-6.56%-89.08%-46.60%
Earnings Yield-2.95%-0.46%-4.53%-2.57%
Efficiency Ratios
Receivables Turnover0.000.000.000.00
Payables Turnover0.000.0016.30117.12
Inventory Turnover0.000.000.000.00
Fixed Asset Turnover4.020.000.160.00
Asset Turnover0.110.000.020.00
Working Capital Turnover Ratio0.280.00-0.010.00
Cash Conversion Cycle0.000.00-22.39-3.12
Days of Sales Outstanding0.000.000.000.00
Days of Inventory Outstanding0.000.000.000.00
Days of Payables Outstanding0.000.0022.393.12
Operating Cycle0.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.89-0.79-1.33-0.24
Free Cash Flow Per Share-0.95-0.81-1.41-0.39
Dividend Paid and CapEx Coverage Ratio-14.82-39.94-16.43-1.50
Capital Expenditure Coverage Ratio-14.82-39.94-16.43-1.50
Operating Cash Flow Coverage Ratio-0.55-0.45-2.87-0.04
Operating Cash Flow to Sales Ratio-0.780.00-19.750.00
Free Cash Flow Yield-2.07%-1.29%-2.32%-0.67%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-33.93-215.35-22.09-38.96
Price-to-Sales (P/S) Ratio40.450.00902.830.00
Price-to-Book (P/B) Ratio6.3035.60-9.28-18.68
Price-to-Free Cash Flow (P/FCF) Ratio-48.39-77.62-43.08-150.22
Price-to-Operating Cash Flow Ratio-51.66-79.56-45.71-250.36
Price-to-Earnings Growth (PEG) Ratio-0.092.41-0.270.00
Enterprise Value Multiple-36.05-253.38-32.20-61.85
Enterprise Value7.04B9.35B8.63B12.11B
EV to EBITDA-36.05-253.38-32.20-61.85
EV to Sales35.680.00884.330.00
EV to Free Cash Flow-42.69-76.75-42.20-162.82
EV to Operating Cash Flow-45.57-78.67-44.77-271.35
Tangible Book Value Per Share7.261.77-6.55-3.17
Shareholders’ Equity Per Share7.271.77-6.55-3.17
Tax and Other Ratios
Effective Tax Rate-0.080.000.000.00
Revenue Per Share1.130.000.070.00
Net Income Per Share-1.35-0.29-2.75-1.52
Tax Burden1.081.001.001.00
Interest Burden1.011.101.381.34
Research & Development to Revenue1.630.0026.040.00
SG&A to Revenue0.470.004.290.00
Stock-Based Compensation to Revenue0.050.001.830.00
Income Quality0.790.390.530.16

Currency in CNY